Literature DB >> 20434807

The role of CD44 and matrix metalloproteinase-9 expression in predicting neck metastasis of supraglottic laryngeal carcinoma.

Imdat Yüce1, Ali Bayram, Sedat Cağlı, Ozlem Canöz, Sevgi Bayram, Ercihan Güney.   

Abstract

AIM: The aim of this study is to evaluate the role of CD44 and matrix metalloproteinase (MMP)-9 expression in predicting neck metastasis of supraglottic laryngeal carcinoma.
MATERIALS AND METHODS: Two hundred ninety-four supraglottic laryngeal cancers were treated surgically from 1991 to 2005. Ninety-four of the 294 patients had pathologically metastatic lymph node (pN+). Among the 94 patients, 30 pN+ patients were selected via random sampling. Sex-, T value-, and differentiation-matched 30 patients who had pathologically negative neck were also selected. CD44 and MMP-9 antibodies were applied to the tumor representative sections that were derived from paraffin sections by using the streptavidin-biotin method. The association between immunohistochemical results and histopathologic lymph node metastasis was analyzed statistically. The association between immunostaining of CD44 and MMP-9 was also analyzed.
RESULTS: Overexpression of CD44 and MMP-9 was found to be significantly higher in pN+ patients. There was fair concordance between immunostaining of CD44 and MMP-9.
CONCLUSION: Although wider multiinstitutional and multidisciplinary studies are needed to draw specific conclusions, CD44 and MMP-9 can be useful in the prediction of neck metastasis in the supraglottic laryngeal carcinoma.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 20434807     DOI: 10.1016/j.amjoto.2010.01.001

Source DB:  PubMed          Journal:  Am J Otolaryngol        ISSN: 0196-0709            Impact factor:   1.808


  10 in total

1.  Divergent roles of CD44 and carcinoembryonic antigen in colon cancer metastasis.

Authors:  Matthew R Dallas; Guosheng Liu; Wei-Chiang Chen; Susan N Thomas; Denis Wirtz; David L Huso; Konstantinos Konstantopoulos
Journal:  FASEB J       Date:  2012-03-13       Impact factor: 5.191

2.  Pre-treatment gelatinases' serum levels and post-treatment changes in laryngeal cancer patients.

Authors:  G Tsiropoulos; T Papadas; Ie Triantaphyllidou; S Naxakis; K Markou; S Triaridis; I Vital; P Goumas; Dh Vynios
Journal:  Hippokratia       Date:  2013-07       Impact factor: 0.471

3.  Matrix Metalloproteinases (MMP-2,-3,-9) Gene Polymorphisms in Cases of Benign Vocal Fold Lesions and Laryngeal Carcinoma.

Authors:  Vykintas Liutkevicius; Vaiva Lesauskaite; Rasa Liutkeviciene; Paulius Vaiciulis; Virgilijus Uloza
Journal:  In Vivo       Date:  2020 Jan-Feb       Impact factor: 2.155

4.  Prognostic significance of the tumour-adjacent tissue in head and neck cancers.

Authors:  Martina Raudenska; Marketa Sztalmachova; Jaromir Gumulec; Michaela Fojtu; Hana Polanska; Jan Balvan; Marek Feith; Hana Binkova; Zuzana Horakova; Rom Kostrica; Rene Kizek; Michal Masarik
Journal:  Tumour Biol       Date:  2015-07-14

Review 5.  Significance of CD44 expression in head and neck cancer: a systemic review and meta-analysis.

Authors:  Jianqiang Chen; Jianding Zhou; Jie Lu; Hua Xiong; Xueli Shi; Liang Gong
Journal:  BMC Cancer       Date:  2014-01-13       Impact factor: 4.430

6.  Characteristics of Expression of Matrix Metalloproteinases (MMP-2 and MMP-9) in Glottic Squamous Cell Carcinoma and Benign Vocal Fold Lesions.

Authors:  Virgilijus Uloza; Vykintas Liutkevicius; Dalia Pangonyte; Vaiva Lesauskaite
Journal:  Clin Exp Otorhinolaryngol       Date:  2015-02-03       Impact factor: 3.372

7.  Role of CD44 as a marker of cancer stem cells in head and neck cancer.

Authors:  Serena Trapasso; Eugenia Allegra
Journal:  Biologics       Date:  2012-11-01

8.  Cancer stem cells in head and neck cancer.

Authors:  Eugenia Allegra; Serena Trapasso
Journal:  Onco Targets Ther       Date:  2012-11-21       Impact factor: 4.147

9.  Recently identified biomarkers that promote lymph node metastasis in head and neck squamous cell carcinoma.

Authors:  Elyse L Walk; Scott A Weed
Journal:  Cancers (Basel)       Date:  2011-02-22       Impact factor: 6.639

Review 10.  The Promise of Novel Biomarkers for Head and Neck Cancer from an Imaging Perspective.

Authors:  Loredana G Marcu; Paul Reid; Eva Bezak
Journal:  Int J Mol Sci       Date:  2018-08-24       Impact factor: 5.923

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.